• Osteopore Ltd enters into $20 million convertible note subscription agreement with Advance Opportunities Fund
• Offer of 400 convertible notes with $50,000 face value each
• Commitment shares to be issued to satisfy $50,000 commitment fee

Osteopore Ltd has announced the launch of a convertible note prospectus, offering 400 convertible notes with a face value of $50,000 each for an aggregate subscription amount of up to $20 million. The company has entered into a subscription agreement with Advance Opportunities Fund and Advance Opportunities Fund I, Cayman Islands-based investment funds, to issue the convertible notes. As part of the agreement, Osteopore will pay a one-time commitment fee of $50,000 to the noteholders, which will be satisfied through the issue of commitment shares at an issue price equivalent to the VWAP of the company's shares for 5 consecutive trading days preceding the closing date of the first four tranches of the first tranche under the subscription agreement.The key terms and conditions of the convertible notes are set out in the prospectus, and investors are advised to read the document in its entirety and seek professional advice where necessary. The convertible notes will not be quoted on the ASX, but the company will apply for official quotation of the shares issued upon conversion of the notes.The purpose of the prospectus is to ensure that the on-sale of the securities does not breach section 707(3) of the Corporations Act, as the offer with respect to the convertible notes is being made such that the relief provided under ASIC Corporations (Offers of Convertibles) Instrument 2016/83 with respect to the on-sale provisions of section 707 of the Corporations Act is available.